PCDC

UMDF, MitoAction Help Lift Up Patient Voices on FDA Listening Session for Pyruvate Dehydrogenase Complex Deficiency (PDCD)

Retrieved on: 
Friday, September 15, 2023
Elizabeth Watts-Russell, UMDF, September 8, Disease, Life, Fear, PCDC, Hope, Philadelphia, Pyruvate dehydrogenase complex, Human voice, MD, Patient, Knowledge, Hospital, Mitochondrial disease, Health, FDA, Death, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Family, Food, Caregiver, Children's Hospital of Philadelphia, Pharmaceutical industry, Medical device, Nursing

PITTSBURGH, Sept. 15, 2023 /PRNewswire-PRWeb/ -- Today, patient advocacy groups, the United Mitochondrial Disease Foundation (UMDF) and MitoAction shared reactions from a listening session with the U.S. Food and Drug Administration (FDA) regarding Pyruvate Dehydrogenase Complex Deficiency (PDCD).

Key Points: 
  • PITTSBURGH, Sept. 15, 2023 /PRNewswire-PRWeb/ -- Today, patient advocacy groups, the United Mitochondrial Disease Foundation (UMDF) and MitoAction shared reactions from a listening session with the U.S. Food and Drug Administration (FDA) regarding Pyruvate Dehydrogenase Complex Deficiency (PDCD).
  • The September 8, 2023 closed virtual session, "The Voice of Pyruvate Dehydrogenase Complex Deficiency Patient Community," was requested by members of the PDCD community to help the FDA understand the disease.
  • This was the second FDA Listening Session UMDF and MitoAction have cohosted for a mitochondrial disease in the last 20 months.
  • In January 2022, the FDA held a similar session for thymidine kinase 2 deficiency (TK2d), another rare mitochondrial disease.

Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs

Retrieved on: 
Wednesday, March 29, 2023
Technology, Insurance, Health Technology, Professional Services, Software, Networks, Practice Management, General Health, Health, Data Management, Partnership, FQHC, VBC, PCDC, Electronic health record, Federally Qualified Health Center, Community, Patient, EHR, Risk, Nursing care plan, Health insurance, Nursing, Vim

Vim , the leading point-of-care connection platform for U.S. healthcare, today announced an agreement with Yuvo Health to make Vim’s EHR-integrated, provider-enablement technology platform available to Yuvo Health’s network of Federally Qualified Health Centers (FQHCs) and Community Health Centers.

Key Points: 
  • Vim , the leading point-of-care connection platform for U.S. healthcare, today announced an agreement with Yuvo Health to make Vim’s EHR-integrated, provider-enablement technology platform available to Yuvo Health’s network of Federally Qualified Health Centers (FQHCs) and Community Health Centers.
  • Vim will provide point-of-care enablement technology for Yuvo Health’s existing FQHC partners in New York state, as well as new partners as it expands and enters new markets.
  • In the initial deployment, Vim will provide its context-aware, read-write capable applications for quality score performance and suspected diagnosis review.
  • Combining the right resources with the right technology makes their lives — and the lives of their patients — easier.”
    Together, Yuvo Health and Vim will help more FQHCs and Community Health Centers more easily transition to value-based care operations.

Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, March 27, 2023
Society, Epilepsy, Food and Drug Administration, Prescription, MSUD, Acquisition, Patent, Patient, Menopause, Collaboration, Celiprolol, Diet, VMS, Contra, Syndrome, UCD, PCDC, Sodium benzoate, Ammonia, CPS, FDA, Body surface area, Maple syrup urine disease, BSA, Liver, SIMD, Hot, Maharishi Sandipani Rashtriya Ved Vidya Pratishthan, Annual report, Blood, ACER, Research, Therapy, Medicaid, Information technology, Clinical trial, United States patent law, Woman, Urea, Sale, State Administrative Expenses, UCD School of Medicine, OTC, Annual general meeting, Food, Pharmaceutical industry, Cryptocurrency, Maple syrup, Acer, Discover

OLPRUVA™ is not used to treat rapid increase of ammonia in the blood (acute hyperammonemia), which can be life-threatening and requires emergency medical treatment.

Key Points: 
  • OLPRUVA™ is not used to treat rapid increase of ammonia in the blood (acute hyperammonemia), which can be life-threatening and requires emergency medical treatment.
  • As a result, Acer is pausing the ACER-801 program until Acer has conducted a thorough review of the full data set
    Ended Q4 2022 with $2.3 million in cash and cash equivalents.
  • Cash and cash equivalents were $2.3 million as of December 31, 2022, compared to $12.7 million as of December 31, 2021.
  • For additional information, please see Acer’s Annual Report on Form 10-K filed today with the SEC.

YUVO HEALTH EXPANDS LEADERSHIP TEAM WITH LOREN ANTHES AS NEW HEAD OF POLICY AND PROGRAMS TO DRIVE HEALTH EQUITY IN OHIO AND BEYOND

Retrieved on: 
Tuesday, January 24, 2023
Cloud, Cloud management, Master of Business Administration, Antes, Baldwin Wallace University, FQHC, Heritage College of Osteopathic Medicine, Ohio University Eastern Campus, The arts, Watts College of Public Service & Community Solutions, Government, Ohio Department of Health, Ohio University, Technical writer, Community, Heritage College, IPA, Bachelor of Arts in Organizational Psychology, Osteopathic medicine in the United States, Health equity, Business administration, SCAN Health Plan, Fidelis Care, Fellow, Patient, Curriculum, PCDC, Management, Health insurance, Nursing, Policy, Anthas, Medicaid

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Yuvo Health, a leading technology-enabled administrative and managed-care solution for community health centers, today announced Loren Anthes as its new Head of Policy and Programs. In addition to Anthes, Yuvo Health has also made the following hires recently: Scrum Master, Birjis Ahmedi; Product Manager, Stephen Fee; Senior Product Manager; Nadia Trapala, IS Cloud Manager, Ajay Joshi; and Technical Writer, Daisy DeKnight. They will report to Head of Product Dakisha Allen and Chief Technology Officer Sujata Bajaj, who both joined the company in October 2022.

Key Points: 
  • NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Yuvo Health , a leading technology-enabled administrative and managed-care solution for community health centers, today announced Loren Anthes as its new Head of Policy and Programs.
  • They will report to Head of Product Dakisha Allen and Chief Technology Officer Sujata Bajaj, who both joined the company in October 2022.
  • An industry-renowned health care policy expert with experience in the public and private sectors, particularly in Medicaid, Anthes offers expertise in government relations, quality improvement, health care finance, policy analysis, data interoperability, and public speaking.
  • To learn more about Yuvo Health and their programs for community health centers, click here .

Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones

Retrieved on: 
Monday, January 9, 2023
MA, Liver, Flash, Caregiver, Trauma, Aircraft pilot, Partnership, Intellectual property, Woman, IVMS, Acquisition, Adenocarcinoma, UCD School of Medicine, Prostate, University, UCD, Ammonia, Epilepsy, Food, Maple syrup urine disease, BSA, ACER, Blood, Education, Therapy, MSUD, Body surface area, Severity, FDA, VED, Post-traumatic stress disorder, VMS, Mouse, United States Department of Defense, Prostate cancer, OTC, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Celiprolol, PCDC, PTSD, Patient, Diet, Emory University, Testosterone, Disorder, CPS, Pharmaceutical industry, Discover, Acer, Osanetant

NEWTON, MA – January 09, 2023 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today announced a corporate update and provided anticipated key development milestones for 2023.

Key Points: 
  • NEWTON, MA – January 09, 2023 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today announced a corporate update and provided anticipated key development milestones for 2023.
  • “Our commitment to patients is the cornerstone of our mission, and we are proud to have secured our first FDA approval.
  • We are eager to report the topline results from our ongoing Phase 2a trial of ACER-801 in moderate to severe VMS in post-menopausal women in Q1 of 2023.
  • These trial results will provide important insight into ACER-801’s therapeutic potential in induced VMS (iVMS).

Governor Hochul Vetoes Primary Care Legislation, Misses Opportunity to Advance Health Equity and Primary Care for Underserved New Yorkers

Retrieved on: 
Thursday, December 1, 2022
United States Department of Veterans Affairs, Capacity building, State, Community development, Policy, Legislation, Financial services, Community development financial institution, Health equity, PCDC, Assembly, Investment, Health insurance, Health

NEW YORK, Dec. 1, 2022 /PRNewswire-PRWeb/ -- Primary Care Development Corporation (PCDC) — a New York-based, national nonprofit and Community Development Financial Institution that aims to increase access to primary care and achieve health equity through strategic community investment, capacity building, and policy initiatives — is deeply disappointed that despite months of careful legislative consideration and strong support from health care providers, advocates, and state lawmakers, Governor Hochul vetoed Assembly Bill 7230B/Senate Bill 6534C.

Key Points: 
  • This legislation would have started a path to better access to quality primary care for New York's most vulnerable communities.
  • PCDC CEO Louise Cohen stated, "We are deeply disappointed that Governor Hochul vetoed this legislation and missed a critical opportunity to advance health equity and improve access to primary care for all New Yorkers.
  • "New York State does not invest enough in primary care despite spending more per capita on health care than the national average.
  • PCDC will continue to advocate alongside advocates, health care providers, and lawmakers to increase investment in primary care and improve access to quality primary care for all New Yorkers.

Yuvo Health Partners With Primary Care Development Corporation (PCDC) To Expand and Support Primary Care Access in Marginalized Communities

Retrieved on: 
Wednesday, September 14, 2022
Health, Efficiency, Policy, FQHC, CDFI, Community development financial institution, Association, Partnership, Capacity building, Community, Health equity, Program, Medicaid, CEO, Federally Qualified Health Center, Community development, New York State Department of Health, Research, PCDC, Fidelis Care, VBP, IPA, BIPOC, Health insurance, Medicine

"We're pleased to partner with Yuvo Health, which shares our deep commitment to both FQHCs and expanding investment in primary care, overall."

Key Points: 
  • "We're pleased to partner with Yuvo Health, which shares our deep commitment to both FQHCs and expanding investment in primary care, overall."
  • In May 2022, Yuvo Health announced four FQHCs that joined the company's independent provider association (IPA): Long Island Select Healthcare, Metro Community Health Centers, Joseph P. Addabbo Family Health Center, and Advantage Care Health Centers.
  • Founded in 1993, the Primary Care Development Corporation (PCDC) is a Community Development Financial Institution and nationally recognized nonprofit organization dedicated to expanding access to quality primary care, in order to improve the health of families and communities, lessen disparities, and reduce health care costs.
  • To date, PCDC has helped over 3,000 primary care practices improve delivery of care and leveraged over $1.3 billion in capital to enhance capacity in disinvested communities.

Bank of America Commits $40 Million to Expand Access to Primary Health Care

Retrieved on: 
Tuesday, June 14, 2022
American Cancer Society, DOI, Social change, Community, Leadership, Capital Impact Partners, JAMA Internal Medicine, Program, Mortality, School, Mental health, Public housing, ESG, FQHC, Health equity, Bank of America, Income, Bank, Public health, CDFI, Partnership, Conditional sentence, Policy, Organization, Center, Workforce, PCDC, University of Michigan School of Public Health, Investment, Multimedia, University, Federally Qualified Health Center, CVS Health, BAC, Growth, Patient, University of Michigan School of Social Work, Employment, Health, Acquisition, NYSE, American Diabetes Association, Twitter, Association, Physician, Population, American Heart Association, CVS, Feeding America, Color, Internal medicine, Hospital, Health insurance, Renewable energy

CHARLOTTE, N.C., June 14, 2022 /PRNewswire/ -- To increase access to health care services in medically underserved communities, Bank of America has committed $40 million in low-cost, long-term capital to finance the development and expansion of community health care centers and other primary care facilities across the United States.

Key Points: 
  • CHARLOTTE, N.C., June 14, 2022 /PRNewswire/ -- To increase access to health care services in medically underserved communities, Bank of America has committed $40 million in low-cost, long-term capital to finance the development and expansion of community health care centers and other primary care facilities across the United States.
  • "Increased investment in primary care improves health outcomes by making primary care more accessible and affordable, and by expanding the health care workforce to provide the services people need in the communities where they live and work," said Ebony Thomas, Bank of America Charitable Foundation President.
  • Over 3.4 million patients are receiving health care at 570 community health centers financed by Capital Impact around the country.
  • Since 2021, Bank of America has invested more than $66 million to address needs related to health in the communities it serves.

First-Of-Its-Kind Project To Use Private-Sector Funding to Reduce Asthma for NYC Medicaid Recipients

Retrieved on: 
Wednesday, January 12, 2022
Social impact, Mortality, Food, CBPR, Community, Industry, Private sector, Corporate sustainability, Policy, Food security, Incidence, COVID-19, Hispanic, Safety, PCDC, Health equity, Hospital, Organization, Partnership, Patient, Capacity building, Medicaid, Health care, Medicare, Molina Healthcare, Association, New York City Department of Health and Mental Hygiene, Color, Michelle McMurry-Heath, Investment, Poverty, Mental Hygiene, CEO, Government, Treasury, Housing, Quality of life, Asthma, Risk, Green, Pharmaceutical industry, Health insurance, Medicine, Health, Northern Trust

"This project captures the vision that funding health-based housing interventions to lower the incidence of asthma is critical to addressing the social determinants of health and equity.

Key Points: 
  • "This project captures the vision that funding health-based housing interventions to lower the incidence of asthma is critical to addressing the social determinants of health and equity.
  • The project aims to reduce serious asthma episodes among 850 children and adults who have chronic asthma.
  • Helping people with asthma manage these issues earlier will reduce costs by preventing avoidable emergency department visits and hospitalizations.
  • Estimates indicate that the project will result in $6.5 million in healthcare savings which more than compensates for the initial investment.

PCDC Urges Governor Hochul to Make Primary Care a Central Focus of Her $10 Billion Health Care Commitment

Retrieved on: 
Friday, January 7, 2022
Mortality, Population, Policy, Disease, PCDC, COVID-19, Color, Community, State, Health status of Asian Americans, Infection, Health equity, COVID, Capacity building, Pharmaceutical industry, Hospital

PCDC wholeheartedly agrees and, as COVID-19 continues to surge into 2022, believes that New York State must move swiftly to strengthen and invest in primary care and the primary care workforce in order to achieve health equity and protect its communities throughout the pandemic era and beyond.

Key Points: 
  • PCDC wholeheartedly agrees and, as COVID-19 continues to surge into 2022, believes that New York State must move swiftly to strengthen and invest in primary care and the primary care workforce in order to achieve health equity and protect its communities throughout the pandemic era and beyond.
  • PCDC applauds the Governor's commitment to investing $10 billion for health care, including for capital infrastructure and to grow the health care workforce by 20 percent over the next five years.
  • We urge all New York leaders to specifically center primary care in this historic investment.
  • "Primary care saves lives, leads to better individual and community health, and is unequivocally central to health equity yet we continue to undervalue and underfund it, which hurts marginalized communities most" said PCDC CEO, Louise Cohen.